Active, not recruitingNCT04928599
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Melissa P BeaucheminChildren's Oncology Group
- Intervention
- Electronic Health Record Review(other)
- Enrollment
- 100 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2028
Study locations (30)
- Kaiser Permanente-Oakland, Oakland, California, United States
- Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
- Broward Health Medical Center, Fort Lauderdale, Florida, United States
- Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
- Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States
- Nemours Children's Hospital, Orlando, Florida, United States
- Sacred Heart Hospital, Pensacola, Florida, United States
- Tampa General Hospital, Tampa, Florida, United States
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States
- Augusta University Medical Center, Augusta, Georgia, United States
- Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States
- Blank Children's Hospital, Des Moines, Iowa, United States
- Children's Hospital New Orleans, New Orleans, Louisiana, United States
- Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04928599 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University